| Cash Flow | 2025-09-30 |
|---|---|
| Net income | 20,885 |
| Depreciation and amortization | 101,433 |
| Deferred income taxes | 5,623 |
| Loss on disposal of assets and impairment charges | -5,486 |
| Gain from sale-leaseback | 20,777 |
| Foreign currency (gain) loss | 76 |
| Gain from issuance of shares as payment of deferred consideration related to business acquisition | 0 |
| Gain from settlement related to business acquisition | 0 |
| Amortization of deferred financing costs and debt discount | 2,107 |
| Amortization of deferred income | -15,344 |
| Accretion of asset retirement obligation | 1,877 |
| Non-cash rent | -9,405 |
| Charges to allowance for credit losses | 819 |
| Income from equity investment | 95 |
| Share-based compensation | 10,878 |
| Fair value adjustment of financial assets and liabilities | -9,109 |
| Other operating activities, net | -191 |
| (increase) decrease in trade receivables | 17,330 |
| Decrease in inventory | -28,218 |
| (increase) decrease in other assets | 9,540 |
| Decrease in accounts payable | -9,506 |
| Increase in other current liabilities | 16,542 |
| Decrease in asset retirement obligation | -604 |
| Increase in non-current liabilities | 27,308 |
| Net cash provided by operating activities | 148,009 |
| Purchase of property and equipment | 97,641 |
| Proceeds from sale of property and equipment | 3,868 |
| Business acquisitions, net of cash | 0 |
| Loans to equity investment, net | -48 |
| Net cash used in investing activities | -93,725 |
| Receipt of long-term debt, net | 37,302 |
| Repayment of debt | 18,624 |
| Principal payments on financing leases | 4,315 |
| Early settlement of deferred consideration related to business acquisition | 0 |
| Common stock repurchased | 20,773 |
| Dividends paid on common stock | 10,288 |
| Dividends paid on redeemable preferred stock | 4,301 |
| Net cash used in financing activities | -20,999 |
| Net increase in cash and cash equivalents and restricted cash | 33,285 |
| Effect of exchange rate changes on cash | 36 |
| Cash and cash equivalents at beginning of period | 292,408 |
| Cash and cash equivalents at end of period | 325,729 |
ARKO Corp. (ARKOW)
ARKO Corp. (ARKOW)